BamSEC and AlphaSense Join Forces
Learn More

Quest Diagnostics Incorporated

NYSE: DGX    
Share price (11/21/24): $163.89    
Market cap (11/21/24): $18.3 billion

Underwriting Agreements Filter

EX-1.1
from 8-K 50 pages Quest Diagnostics Incorporated (A Delaware Corporation) $400,000,000 4.600% Senior Notes Due 2027 $600,000,000 4.625% Senior Notes Due 2029 $850,000,000 5.000% Senior Notes Due 2034 Underwriting Agreement
12/34/56
EX-1.1
from 8-K 44 pages Quest Diagnostics Incorporated (A Delaware Corporation) $750,000,000 6.400% Senior Notes Due 2033 Underwriting Agreement
12/34/56
EX-1.1
from 8-K 44 pages Quest Diagnostics Incorporated (A Delaware Corporation) $550,000,000 2.800% Senior Notes Due 2031 Underwriting Agreement
12/34/56
EX-1.1
from 8-K 42 pages Quest Diagnostics Incorporated (A Delaware Corporation) $800,000,000 2.950% Senior Notes Due 2030 Underwriting Agreement
12/34/56
EX-1.1
from 8-K 42 pages Quest Diagnostics Incorporated (A Delaware Corporation) $500,000,000 4.200% Senior Notes Due 2029 Underwriting Agreement
12/34/56
EX-1.1
from 8-K 40 pages Quest Diagnostics Incorporated (A Delaware Corporation) $500,000,000 3.450% Senior Notes Due 2026 Underwriting Agreement
12/34/56
EX-1.1
from 8-K 43 pages Quest Diagnostics Incorporated (A Delaware Corporation) $300,000,000 2.500% Senior Notes Due 2020 $600,000,000 3.500% Senior Notes Due 2025 $300,000,000 4.700% Senior Notes Due 2045 Underwriting Agreement
12/34/56
EX-1.1
from 8-K 41 pages Quest Diagnostics Incorporated (A Delaware Corporation) $300,000,000 2.700% Senior Notes Due 2019 $300,000,000 4.250% Senior Notes Due 2024 Underwriting Agreement
12/34/56
EX-1.1
from 8-K 54 pages Quest Diagnostics Incorporated (A Delaware Corporation) $300,000,000 3.200% Senior Notes Due 2016 $550,000,000 4.700% Senior Notes Due 2021 $200,000,000 5.750% Senior Notes Due 2040 $200,000,000 Floating Rate Senior Notes Due 2014 Underwriting Agreement
12/34/56
EX-1.1
from 8-K 42 pages Quest Diagnostics Incorporated (A Delaware Corporation) Common Stock, Par Value $0.01 Per Share Underwriting Agreement
12/34/56
EX-1.1
from 8-K 49 pages Quest Diagnostics Incorporated (A Delaware Corporation) $500,000,000 4.750% Senior Notes Due 2020 $250,000,000 5.750% Senior Notes Due 2040 Underwriting Agreement
12/34/56
EX-1.1
from 8-K ~50 pages Underwriting Agreement
12/34/56
EX-1.1
from 8-K ~50 pages Purchase Agreement
12/34/56
EX-1
from 8-K ~10 pages Underwriting agreement
12/34/56
EX-1
from S-1/A ~50 pages Underwriting Agreement
12/34/56